Lonza Group AG | WebDisclosure

Basculer en Français

10663	Companies
227159	Keywords
155552	Articles
120271	Press releases

Home
Companies
Lonza Group AG

PRESS RELEASE

published on 10/22/2024 at 07:00, 1 year 8 months ago

Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza extends collaboration with major pharmaceutical partner for integrated commercial supply of antibody-drug conjugates, including construction of dedicated bioconjugation capacity in Visp, and commercial antibody manufacturing for new ADC therapy

Lonza ADCs Commercial Supply Bioconjugation Pharmaceutical Partner
BRIEF

published on 10/03/2024 at 09:05, 1 year 8 months ago

Lonza Nominates David Meline as Independent Board Member

Board Of Directors Annual General Meeting Financial Experience Lonza Group David Meline
BRIEF

published on 10/03/2024 at 09:05, 1 year 8 months ago

Lonza nomme David Meline au poste de membre indépendant du conseil d'administration

Conseil D'administration Assemblée Générale Annuelle Expérience Financière Groupe Lonza David Meline
PRESS RELEASE

published on 10/03/2024 at 09:00, 1 year 8 months ago

Lonza Nominates David Meline as Independent Board Member
Lonza nominates David Meline, experienced CFO, for Board position. Olivier Verscheure not to seek re-election. Details on David's background and Lonza's activities

CFO Lonza Board Member David Meline Olivier Verscheure
BRIEF

published on 10/01/2024 at 16:50, 1 year 8 months ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville

Acquisition Pharmaceuticals Lonza Biologics Vacaville
BRIEF

published on 10/01/2024 at 16:50, 1 year 8 months ago

Lonza finalise l'acquisition d'un site de produits biologiques à grande échelle à Vacaville

Acquisition Lonza Médicaments Produits Biologiques Vacaville
PRESS RELEASE

published on 10/01/2024 at 16:45, 1 year 8 months ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche, expanding US footprint and manufacturing capacity

Acquisition Manufacturing Lonza Roche Biologics
BRIEF

published on 09/24/2024 at 14:05, 1 year 9 months ago

Lonza and Vertex Sign Long-Term Supply Agreement for CASGEVY®

Lonza Cell Therapy Vertex CASGEVY® CRISPR/Cas9
BRIEF

published on 09/24/2024 at 14:05, 1 year 9 months ago

Lonza et Vertex signent un accord d'approvisionnement à long terme pour CASGEVY®

Lonza Sommet Thérapie Cellulaire CASGEVY® CRISPR/Cas9
PRESS RELEASE

published on 09/24/2024 at 14:00, 1 year 9 months ago

Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza and Vertex sign a long-term commercial supply agreement for CASGEVY® cell therapy based on CRISPR/Cas9 gene-editing technology. Lonza to manufacture at Geleen, NL facility approved by FDA, EMA, and MHRA

Lonza Cell Therapy Vertex CASGEVY® CRISPR/Cas9

Accesswire

Published on 06/30/2026 at 15:00, 1 hour 21 minutes ago

Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 1 hour 21 minutes ago

BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 1 hour 21 minutes ago

Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 1 hour 51 minutes ago

NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 2 hours 21 minutes ago

Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative

View all ACCESSWIRE

EQS Group

Published on 06/30/2026 at 16:07, 14 minutes ago

RM plc: Holding(s) in Company
Published on 06/30/2026 at 16:05, 16 minutes ago

Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 15:37, 44 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 06/30/2026 at 15:34, 47 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 06/30/2026 at 15:29, 52 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 06/30/2026 at 15:06, 1 hour 15 minutes ago

260630 BENETEAU Transactions sur actions propres
Published on 06/30/2026 at 07:30, 8 hours 51 minutes ago

Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 8 hours 51 minutes ago

Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Published on 06/30/2026 at 07:30, 8 hours 51 minutes ago

Acquisition of Harwanne Capital Management
Published on 06/30/2026 at 07:30, 8 hours 51 minutes ago

Acquisition de Harwanne Capital Management

View all LES ECHOS COMFI WIRE